NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.

Authors

Cheng Wang
Zaiming Luo
Gabriella Carter
Anton Wellstein
Pedro A Jose, George Washington University
James Tomlinson
James Leiper
William J Welch
Christopher S Wilcox
Dan Wang

Document Type

Journal Article

Publication Date

3-1-2018

Journal

American journal of physiology. Regulatory, integrative and comparative physiology

Volume

314

Issue

3

Inclusive Pages

R399-R406

DOI

10.1152/ajpregu.00122.2017

Keywords

Angiotensin II; Animals; Antihypertensive Agents; Arginine; Arterial Pressure; Biomarkers; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Hydroquinones; Hypertension; Male; Mice, Inbred C57BL; Mice, Knockout; Microvessels; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Signal Transduction; Thromboxane B2; Time Factors; Up-Regulation; Vascular Remodeling; Vasoconstriction

APA Citation

Wang, C., Luo, Z., Carter, G., Wellstein, A., Jose, P., Tomlinson, J., Leiper, J., Welch, W., Wilcox, C., & Wang, D. (2018). NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.. American journal of physiology. Regulatory, integrative and comparative physiology, 314 (3). http://dx.doi.org/10.1152/ajpregu.00122.2017

Peer Reviewed

1